Figure 4f shows that DLGAP5 was significantly expressed in the TCGA data set of pancreatic cancer, and DLGAP5 expression levels had a great effect on patients’ overall survival (OS) and progression-free survival (PFS) (Fig. 4g, h). Here, DLGAP5 is linked to pancreatic neoplasm.